{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T15:43:39Z","timestamp":1782920619797,"version":"3.54.5"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1016\/j.jaci.2003.10.002","type":"journal-article","created":{"date-parts":[[2004,1,2]],"date-time":"2004-01-02T05:29:21Z","timestamp":1073021361000},"page":"134-140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":90,"title":["The addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test results"],"prefix":"10.1016","volume":"113","author":[{"given":"Scott E.","family":"Bagenstose","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2003.10.002_BIB1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0091-6749(89)90173-5","article-title":"Leukotrienes, LTC4 and LTB4, in bronchoalveolar lavage in bronchial asthma and other respiratory diseases","volume":"84","author":"Wardlaw","year":"1989","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2003.10.002_BIB2","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1046\/j.1365-2222.2002.01425.x","article-title":"Expression and localization of the cysteinyl leukotriene 1 receptor in human nasal mucosa","volume":"32","author":"Shirasaki","year":"2002","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2003.10.002_BIB3","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1164\/ajrccm\/141.4_Pt_1.978","article-title":"The preclinical pharmacology of ICI 204,219: a peptide leukotriene antagonist","volume":"141","author":"Krell","year":"1990","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jaci.2003.10.002_BIB4","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/1523-1747.ep12525225","article-title":"Vascular effects of leukotriene D4 in human skin","volume":"88","author":"Bisgaard","year":"1987","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2003.10.002_BIB5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/1523-1747.ep12531738","article-title":"Local effects of synthetic leukotrienes (LTC4, LTD4, LTE4, and LTB4) in human skin","volume":"80","author":"Soter","year":"1983","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2003.10.002_BIB6","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1056\/NEJMcp011186","article-title":"Clinical practice: chronic urticaria and angioedema","volume":"346","author":"Kaplan","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2003.10.002_BIB7","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0022-3565(25)21635-4","article-title":"Production and antagonism of cutaneous vascular permeability in the guinea pig in response to histamine, leukotrienes and A23187","volume":"230","author":"Rinkema","year":"1984","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jaci.2003.10.002_BIB8","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0091-6749(91)90217-C","article-title":"The effect of the oral leukotriene antagonist, ICI 204,219, on leukotriene D4 and histamine-induced cutaneous vascular reactions in man","volume":"87","author":"Bernstein","year":"1991","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2003.10.002_BIB9","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1067\/mai.2002.126676","article-title":"The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single-blind, placebo-controlled, crossover clinical study","volume":"110","author":"Erbagci","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2003.10.002_BIB10","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1046\/j.1365-2222.2001.01189.x","article-title":"Efficacy of leukotriene receptor antagonist in chronic urticaria: a double-blind, placebo-controlled comparison of treatment with montelukast and cetirizine in patients with chronic urticaria with intolerance to food additive and\/or acetylsalicylic acid","volume":"31","author":"Pacor","year":"2001","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2003.10.002_BIB11","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1046\/j.1365-2222.2002.01536.x","article-title":"Zafirlukast has no beneficial effects in the treatment of chronic urticaria","volume":"32","author":"Reimers","year":"2002","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2003.10.002_BIB12","series-title":"Allergy: principles and practice","first-page":"612","article-title":"Antihistamines","author":"Simons","year":"1998"},{"key":"10.1016\/j.jaci.2003.10.002_BIB13","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1177\/106002809603001001","article-title":"Cetirizine versus hydroxyzine and placebo in chronic idiopathic urticaria","volume":"30","author":"Breneman","year":"1996","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jaci.2003.10.002_BIB14","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0091-6749(98)70176-9","article-title":"Comparative studies of functional and binding assays for IgG anti-Fc(episilon)RI alpha-subunit in chronic urticaria","volume":"101","author":"Ferrer","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2003.10.002_BIB15","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1046\/j.1365-2133.1999.02707.x","article-title":"The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria","volume":"140","author":"Sabroe","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2003.10.002_BIB16","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0091-6749(98)70283-0","article-title":"Anti-Fc(epsilon)RI auto antibodies and basophil histamine releasability in chronic idiopathic urticaria","volume":"102","author":"Sabroe","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2003.10.002_BIB17","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1172\/JCI511","article-title":"Anti-Fc(epsilon)RI alpha autoantibodies in autoimmune-mediated disorders: identification of a structure-function relationship","volume":"101","author":"Fiebiger","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2003.10.002_BIB18","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1365-4362.1992.tb03957.x","article-title":"Comparative efficacy of loratadine and terfenadine in the treatment of chronic idiopathic urticaria","volume":"31","author":"Shareeah","year":"1992","journal-title":"Int J Derm"},{"key":"10.1016\/j.jaci.2003.10.002_BIB19","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1398-9995.1993.tb02406.x","article-title":"A comparison of the efficacy of cetirizine and terfenadine: a double-blind, controlled study of chronic idiopathic urticaria","volume":"48","author":"Andri","year":"1993","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2003.10.002_BIB20","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1398-9995.1996.tb00092.x","article-title":"Efficacy of mizolastine, a new antihistamine, compared with placebo in the treatment of chronic idiopathic urticaria","volume":"51","author":"Brostoff","year":"1996","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2003.10.002_BIB21","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0091-6749(99)70091-6","article-title":"A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria","volume":"104","author":"Finn","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2003.10.002_BIB22","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1046\/j.1365-2133.2000.03664.x","article-title":"Randomized double-blind study of cyclosporin in chronic \u2018idiopathic\u2019 urticaria","volume":"143","author":"Grattan","year":"2000","journal-title":"Br J Derm"},{"key":"10.1016\/j.jaci.2003.10.002_BIB23","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1346-8138.2001.tb00137.x","article-title":"Stanozolol in chronic idiopathic urticaria: z double blind, placebo-controlled trial","volume":"28","author":"Parsad","year":"2001","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaci.2003.10.002_BIB24","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000066772","article-title":"Secretion of cytokines, histamine and leukotrienes in chronic urticaria","volume":"129","author":"Ferrer","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2003.10.002_BIB25","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1365-2222.1991.tb03198.x","article-title":"Detection of circulating histamine releasing autoantibodies with functional properties of anti-IgE in chronic urticaria","volume":"21","author":"Gratton","year":"1991","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2003.10.002_BIB26","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S1081-1206(10)61941-2","article-title":"Successful treatment of autoimmune chronic idiopathic urticaria with intravenous cyclophosphamide","volume":"89","author":"Bernstein","year":"2002","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2003.10.002_BIB27","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1398-9995.1997.tb00996.x","article-title":"Low-dose cyclosporin A in the treatment of severe chronic idiopathic urticaria","volume":"52","author":"Toubi","year":"1997","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2003.10.002_BIB28","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/264258a0","article-title":"Absence of intestinal mast cell response in congenitally athymic mice during Trichinella spiralis infection","volume":"264","author":"Ruitenberd","year":"1976","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2003.10.002_BIB29","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1146\/annurev.immunol.15.1.505","article-title":"Cytokine regulation of host defense against parasitic gastrointestinal nematodes: lessons from studies with rodent models","volume":"15","author":"Finkelman","year":"1997","journal-title":"Ann Rev Immunol"},{"key":"10.1016\/j.jaci.2003.10.002_BIB30","first-page":"174","article-title":"Effects of interleukins on connective tissue type mast cells co-cultured with fibroblasts","volume":"72","author":"Levi-Schaffer","year":"1991","journal-title":"Immunology"},{"key":"10.1016\/j.jaci.2003.10.002_BIB31","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0301-472X(00)00161-2","article-title":"Stem cell factor and interleukin-4 increase responsiveness of mast cells to substance P","volume":"28","author":"Darimi","year":"2000","journal-title":"Exp Hematol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674903024114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674903024114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:49:21Z","timestamp":1758775761000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674903024114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["S0091674903024114"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2003.10.002","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2004,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test results","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2003.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 American Academy of Allergy, Asthma and Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}